The Cross-Boundary Integration Of Breast Biopsy Needles in Minimally Invasive Therapy And Interventional Radiology

https://www.sirius-medical.com/knowledge/breast-biopsy-needle-techniques

For a long time, breast biopsy needles were regarded as purely diagnostic tools. However, with the development of interventional radiology and minimally invasive surgery, this small needle is undergoing a profound role transformation-evolving from a "scout" to a "special forces soldier," integrating diagnosis, treatment, marking, and monitoring, opening a brand-new paradigm in breast disease management.

1. Diagnosis as Treatment: Therapeutic Applications of Vacuum-Assisted Excision

Vacuum-Assisted Biopsy (VAB) systems were initially designed to obtain large-volume tissue samples, but doctors soon discovered they could be used to completely excise small benign tumors. For benign breast tumors (such as fibroadenomas, papillomas) less than 2cm in diameter, VAB can serve as a minimally invasive excision method akin to day surgery. Compared with traditional surgical excision, it only requires a 3-5mm incision, leaves no obvious scars, and offers an extremely short recovery time. In this application, the biopsy needle's rotary blade and vacuum system are given the new mission of "excision tools," achieving "diagnosis and treatment in one step."

2. The "Road Sign" for Precise Localization: Biopsy Needles and Preoperative Wire Localization

For non-palpable lesions (such as microcalcification clusters), accurate preoperative localization is key to successful breast-conserving surgery. The traditional wire localization method involves inserting a hooked metal wire into the center of the lesion via a biopsy needle. Modern radioactive seed localization and magnetic seed localization technologies further upgrade the function of the biopsy needle. Using the coaxial cannula of the biopsy needle, the doctor precisely implants a radioactive iodine-125 particle or ferromagnetic particle, smaller than a grain of rice, into the lesion. During surgery, the doctor uses a gamma probe or magnetic induction detector to find the particle, thereby excising the lesion precisely. Here, the biopsy needle plays the role of a "precision delivery vehicle," sending the localization beacon to the predetermined coordinates.

3. The "Vanguard" of Ablation Therapy: Integrated Biopsy-Ablation Needles

Thermal ablation techniques (radiofrequency, microwave, cryoablation) are becoming effective treatments for early breast cancer and recurrent foci. New integrated biopsy-ablation needles have emerged. This type of needle integrates a biopsy notch and an ablation electrode at the distal end. The doctor first uses this needle for biopsy to confirm the pathological nature; subsequently, without withdrawing the needle, switches to ablation mode with one click to thermally coagulate and necrotize the lesion. The whole process is seamless, avoiding the risk of secondary puncture and realizing "two uses with one needle." This requires the needle material to possess both good electrical/thermal conductivity and mechanical strength, posing extremely high demands on design and manufacturing processes.

4. The "Expressway" for Drug Delivery: Biopsy Needles and Local Chemotherapy/Immunotherapy

Tumor heterogeneity means systemic administration may not achieve effective concentrations at all lesion sites. Channels established by biopsy needles can enable intratumoral injection. For example, after biopsy, the doctor can inject chemotherapeutic drugs, immune agonists, or oncolytic viruses into the tumor through the same needle. This "local intensification" strategy aims to activate the local immune microenvironment of the tumor, produce an "abscopal effect," and even suppress metastases at uninjected sites. In the future, smart-responsive hydrogels or nanoparticle carriers can also be injected via biopsy needles to form drug reservoirs, achieving sustained release therapy for several weeks.

5. The "Sentinel" for Efficacy Monitoring: Complementary Roles of Repeat Biopsy and Liquid Biopsy

During targeted or immunotherapy, tumors may develop resistance or transform. Regular repeat biopsy is the gold standard for monitoring tumor evolution. The low-trauma nature of modern biopsy needles makes repeat biopsies possible. By comparing the genetic profiles of biopsy samples before and after treatment, doctors can adjust medication plans in a timely manner. At the same time, tissue obtained via biopsy needles is also the best material for establishing patient-derived organoids (PDOs) for in vitro drug sensitivity testing, guiding subsequent treatment.

Summary:

The boundaries of breast biopsy needles are blurring. It no longer solely belongs to pathology and imaging departments, but has become a universal platform for multidisciplinary collaboration (MDT) among interventional radiology, medical oncology, and breast surgery. Future breast biopsy needles will be multifunctional miniature surgical platforms integrating sampling, diagnosis, localization, ablation, drug delivery, and monitoring. Every advancement of this needle means breast cancer patients take a big step toward the goals of "more accurate diagnosis, less trauma, and better efficacy."